Form 4 for QDEL QuidelOrtho Corp
Accepted 2022-06-01 00:00:00 ET · period of report 2022-05-27 · accession 0000899243-22-020508 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-01 | 2022-05-27 | QDEL | BRYANT DOUGLAS C | COB, CEO, Dir | A - Grant | — | +505.9K | 505.9K | New | — |
| DM | 2022-06-01 | 2022-05-27 | QDEL | BRYANT DOUGLAS C | COB, CEO, Dir | A - Grant | $0.00 | +293.6K | 27.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-27 | A | A | 505,926 | — | 505,926 | D | — | — | (F1) Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho. |
| 2 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 20,249 | $0.00 | 20,249 | D | $21.08 · — to 2027-02-15 | 20,249 Common Stock | (F3) Vested in full. |
| 3 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 3,347 | $0.00 | 3,347 | D | — · — to — | 3,347 Common Stock | (F10) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F16) 1,115 shares will vest on February 1, 2023; the remaining 2,232 shares will vest in equal installments on February 1, 2024 and February 1, 2025. |
| 4 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 37,440 | $0.00 | 37,440 | D | $59.12 · — to 2029-02-04 | 37,440 Common Stock | (F4) 28,080 shares are vested in full; 9,360 shares will vest on February 4, 2023. |
| 5 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 30,358 | $0.00 | 30,358 | D | $77.16 · — to 2030-02-03 | 30,358 Common Stock | (F5) 15,180 shares are vested in full; the remaining 15,178 shares will vest in equal installments on February 3, 2023 and February 3, 2024. |
| 6 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 10,593 | $0.00 | 10,593 | D | $228.21 · — to 2030-08-24 | 10,593 Common Stock | (F6) 3,531 shares are vested in full; the remaining 7,062 shares will vest in equal installments on August 24, 2022 and August 24, 2023. |
| 7 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 8,924 | $0.00 | 8,924 | D | $254.00 · — to 2031-02-01 | 8,924 Common Stock | (F7) 2,231 shares are vested in full; the remaining 6,693 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025. |
| 8 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 11,140 | $0.00 | 11,140 | D | $142.45 · — to 2031-07-28 | 11,140 Common Stock | (F8) 3,713 shares will vest on July 28, 2022; 3,713 shares will vest on July 28, 2023; and 3,714 shares will vest on July 28, 2024. |
| 9 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 27,043 | $0.00 | 27,043 | D | $103.36 · — to 2032-01-31 | 27,043 Common Stock | (F9) 6,760 shares will vest on January 31, 2023; the remaining 20,283 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026. |
| 10 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 18,720 | $0.00 | 18,720 | D | — · — to — | 18,720 Common Stock | (F10) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F12) 18,720 shares will vest on February 4, 2023. |
| 11 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 7,309 | $0.00 | 7,309 | D | — · — to — | 7,309 Common Stock | (F10) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F13) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| 12 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 2,192 | $0.00 | 2,192 | D | — · — to — | 2,192 Common Stock | (F10) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F13) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| 13 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 7,590 | $0.00 | 7,590 | D | — · — to — | 7,590 Common Stock | (F10) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F14) 7,590 shares will vest in equal installments on February 3, 2023 and February 3, 2024. |
| 14 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 2,921 | $0.00 | 2,921 | D | — · — to — | 2,921 Common Stock | (F10) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F15) 1,460 shares will vest on August 24, 2022 and 1,461 shares will vest on August 24, 2023. |
| 15 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 23,461 | $0.00 | 23,461 | D | $15.40 · — to 2026-02-10 | 23,461 Common Stock | (F3) Vested in full. |
| 16 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 794 | $0.00 | 794 | D | — · — to — | 794 Common Stock | (F10) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F19) 794 shares will vest on January 31, 2023. (F13) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| 17 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 2,646 | $0.00 | 2,646 | D | — · — to — | 2,646 Common Stock | (F10) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F13) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| 18 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 24,187 | $0.00 | 24,187 | D | — · — to — | 24,187 Common Stock | (F10) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F18) 12,093 shares will vest on January 31, 2024; the remaining 12,094 shares will vest in equal installments on January 31, 2025 and January 31, 2026. |
| 19 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 27,043 | $0.00 | 27,043 | D | — · — to — | 27,043 Common Stock | (F10) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F17) 6,760 shares will vest on January 31, 2023; the remaining 20,283 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026. |
| 20 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 27,637 | $0.00 | 27,637 | D | $46.41 · — to 2028-01-16 | 27,637 Common Stock | (F3) Vested in full. |